Literature DB >> 10732316

Periovulatory and interleukin-1 beta-dependent up-regulation of intraovarian vascular endothelial growth factor (VEGF) in the rat: potential role for VEGF in the promotion of periovulatory angiogenesis and vascular permeability.

E Levitas1, D Chamoun, L C Udoff, M Ando, C E Resnick, E Y Adashi.   

Abstract

Vascular endothelial growth factor (VEGF) is an endothelial cell mitogen and permeability factor the role of which in ovarian angiogenesis has been the subject of increasing interest. It was the objective of this communication to explore the possibility that interleukin (IL)-1 may regulate the in vitro expression of rat ovarian VEGF mRNA, as well as to study the in vivo expression of rat ovarian VEGF transcripts during follicular maturation, ovulation, and corpora lutea formation. Taken together, our findings 1) reaffirm the rat ovary as a site of VEGF expression; 2) document an in vivo increase in VEGF transcripts before ovulation; 3) disclose a marked dependence of VEGF on IL-1 beta; 4) reveal the IL-1 beta effect to be receptor mediated and dose and time dependent and to be shared by at least two growth factors--epidermal growth factor and basic fibroblastic growth factor; and 5) demonstrate a lack of VEGF effect on ovarian progesterone biosynthesis as assessed in cultured isolated granulosa cells. It is tempting to speculate that the up-regulatory effect of IL-1 beta on VEGF transcripts may be relevant to the marked angiogenesis and increased vascular permeability displayed by the hyperemic ovarian Graafian follicle during the terminal stages of follicular development. In this context, VEGF may be joined by other IL-1-dependent angiogenesis promoters such as IL-6 or transforming growth factor beta 1. Thus, IL-1-mediated VEGF induction may constitute one of several end points through which IL-1 may coordinate and perhaps amplify the ovulatory cascade.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10732316     DOI: 10.1016/s1071-5576(99)00066-0

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  7 in total

1.  Significance of ovarian macrophages in the follicular aspirates from ART patients.

Authors:  Rosa Inés Barañao; Ramiro Quintana; Alina Martín; Laura Kopcow; Guillermo Marconi; Carlos Sueldo
Journal:  J Assist Reprod Genet       Date:  2007-02-16       Impact factor: 3.412

2.  Genotypic divergence in mouse oocyte transcriptomes: possible pathways to hybrid vigor impacting fertility and embryogenesis.

Authors:  Ashley L Severance; Uros Midic; Keith E Latham
Journal:  Physiol Genomics       Date:  2019-12-23       Impact factor: 3.107

3.  Cytokines in older patients undergoing in vitro fertilization: the relationship to the response to controlled ovarian hyperstimulation.

Authors:  A Pellicer; N Garrido; C Albert; J Navarro; J Remohí; C Simón
Journal:  J Assist Reprod Genet       Date:  1999-05       Impact factor: 3.412

4.  Gene expression analysis of follicular cells revealed inflammation as a potential IVF failure cause.

Authors:  Chloé S Fortin; Arthur Leader; Neal Mahutte; Scot Hamilton; Marie-Claude Léveillé; Marc Villeneuve; Marc-André Sirard
Journal:  J Assist Reprod Genet       Date:  2019-04-18       Impact factor: 3.412

5.  Anti-macrophage inhibitory factor antibody inhibits PMSG-hCG-induced follicular growth and ovulation in mice.

Authors:  Toshiki Matsuura; Motoi Sugimura; Takayuki Iwaki; Ryota Ohashi; Naohiro Kanayama; Jun Nishihira
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

6.  Expressions of VEGF and Ki-67 in eutopic endometrium of patients with endometriosis and effect of Quyu Jiedu Recipe on VEGF expression.

Authors:  Fang Lian; Hai-ping Liu; Yun-xia Wang; Jian-wei Zhang; Zhen-gao Sun; Feng-mei Ma; Ning Zhang; Yan-he Liu; Qian Meng
Journal:  Chin J Integr Med       Date:  2007-06       Impact factor: 1.978

Review 7.  The contribution of the maternal immune system to the establishment of pregnancy in cattle.

Authors:  Trudee Fair
Journal:  Front Immunol       Date:  2015-01-28       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.